Sirtuin 6 Is a Critical Epigenetic Regulator of Cancer
- PMID: 36301499
- DOI: 10.1007/978-3-031-07634-3_10
Sirtuin 6 Is a Critical Epigenetic Regulator of Cancer
Abstract
Sirtuin 6 (SIRT6) is a member of the mammalian sirtuin family with deacetylase, deacylase, and mono-ADP-ribosyl-transferase activities. It is a multitasking chromatin-associated protein regulating different cellular and physiological functions in cells. Specifically, SIRT6 dysfunction is implicated in several aging-related human diseases, including cancer. Studies indicate that SIRT6 has a tumor-specific role, and it is considered a tumor suppressor as well as a tumor growth inducer, depending on the type of cancer. In this chapter, we review the role of SIRT6 in metabolism, genomic stability, and cancer. Further, we provide an insight into the interplay of the tumor-suppressing and oncogenic roles of SIRT6 in cancer. Additionally, we discuss the use of small-molecule SIRT6 modulators as potential therapeutics.
Keywords: Aging; Cancer; Genome instability; Metabolism; SIRT6.
© 2022. The Author(s), under exclusive license to Springer Nature Switzerland AG.
Similar articles
-
Biological and catalytic functions of sirtuin 6 as targets for small-molecule modulators.J Biol Chem. 2020 Aug 7;295(32):11021-11041. doi: 10.1074/jbc.REV120.011438. Epub 2020 Jun 9. J Biol Chem. 2020. PMID: 32518153 Free PMC article. Review.
-
SIRT6, a Mammalian Deacylase with Multitasking Abilities.Physiol Rev. 2020 Jan 1;100(1):145-169. doi: 10.1152/physrev.00030.2018. Epub 2019 Aug 22. Physiol Rev. 2020. PMID: 31437090 Free PMC article. Review.
-
Chromatin and beyond: the multitasking roles for SIRT6.Trends Biochem Sci. 2014 Feb;39(2):72-81. doi: 10.1016/j.tibs.2013.12.002. Epub 2014 Jan 14. Trends Biochem Sci. 2014. PMID: 24438746 Free PMC article. Review.
-
SIRT6: Novel Mechanisms and Links to Aging and Disease.Trends Endocrinol Metab. 2017 Mar;28(3):168-185. doi: 10.1016/j.tem.2016.10.002. Epub 2016 Nov 9. Trends Endocrinol Metab. 2017. PMID: 27836583 Free PMC article. Review.
-
Emerging roles of SIRT6 in human diseases and its modulators.Med Res Rev. 2021 Mar;41(2):1089-1137. doi: 10.1002/med.21753. Epub 2020 Dec 16. Med Res Rev. 2021. PMID: 33325563 Free PMC article. Review.
References
-
- Albani D, Polito L, Forloni G (2010) Sirtuins as novel targets for Alzheimer’s disease and other neurodegenerative disorders: experimental and genetic evidence. J Alzheimers Dis 19(1):11–26. https://doi.org/10.3233/JAD-2010-1215 - DOI - PubMed
-
- Antonia C, Debora S, Stefania O, Giovanna T, Paola M, Fabio G, Veronica R, Nicoletta C, Enrico C, Marino C, Maurizio M, Micaela B, Aimable N, Michel D, Katia T, Antonino N, Mario P, Santina B, Alessio N, Francesco B, Marco G, Roberto ML, Michele C (2018) Depletion of SIRT6 enzymatic activity increases acute myeloid leukemia cells’ vulnerability to DNA-damaging agents. Haematologica 103(1):80–90. https://doi.org/10.3324/haematol.2017.176248 - DOI
-
- Ardestani PM, Liang F (2012) Sub-cellular localization, expression and functions of Sirt6 during the cell cycle in HeLa cells. Nucleus 3(5):442–451. https://doi.org/10.4161/nucl.21134 - DOI - PubMed - PMC
-
- Ashraf N, Zino S, Macintyre A, Kingsmore D, Payne AP, George WD, Shiels PG (2006) Altered sirtuin expression is associated with node-positive breast cancer. Br J Cancer 95(8):1056–1061. https://doi.org/10.1038/sj.bjc.6603384 - DOI - PubMed - PMC
-
- Bai L, Lin G, Sun L, Liu Y, Huang X, Cao C, Guo Y, Xie C (2016) Upregulation of SIRT6 predicts poor prognosis and promotes metastasis of non-small cell lung cancer via the ERK1/2/MMP9 pathway. Oncotarget 7(26):40377–40386. https://doi.org/10.18632/oncotarget.9750 - DOI - PubMed - PMC
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources